These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8295214)

  • 61. Preferential inhibition by a novel Na(+)/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channel.
    Oka M; Itoh Y; Ukai Y
    J Pharmacol Exp Ther; 2000 May; 293(2):522-9. PubMed ID: 10773024
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular ions during veratridine-induced neurotoxicity in hippocampal slices: neuroprotective effects of flunarizine and tetrodotoxin.
    Ashton D; Willems R; Marrannes R; Janssen PA
    Brain Res; 1990 Oct; 528(2):212-22. PubMed ID: 2271923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of L- and N-type Ca2+ channel antagonists on excitatory amino acid-evoked dopamine release.
    Chaudieu I; Alonso R; Mount H; Quirion R; Boksa P
    Eur J Pharmacol; 1992 Sep; 220(2-3):203-9. PubMed ID: 1385182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
    Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
    Vamecq J; Bac P; Herrenknecht C; Maurois P; Delcourt P; Stables JP
    J Med Chem; 2000 Apr; 43(7):1311-9. PubMed ID: 10753468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential inhibition of catecholamine secretion by amitriptyline through blockage of nicotinic receptors, sodium channels, and calcium channels in bovine adrenal chromaffin cells.
    Park TJ; Shin SY; Suh BC; Suh EK; Lee IS; Kim YS; Kim KT
    Synapse; 1998 Jul; 29(3):248-56. PubMed ID: 9635895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and antiarrhythmic activity of alpha, alpha-bis[(dialkylamino)alkyl]phenylacetamides.
    Yonan PK; Novotney RL; Woo CM; Prodan KA; Hershenson FM
    J Med Chem; 1980 Oct; 23(10):1102-8. PubMed ID: 7420355
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.
    Padmanabhan S; Lavin RC; Thakker PM; Guo J; Zhang L; Moore D; Perlman ME; Kirk C; Daly D; Burke-Howie KJ; Wolcott T; Chari S; Berlove D; Fischer JB; Holt WF; Durant GJ; McBurney RN
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3151-5. PubMed ID: 11720863
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ligand and counteranion enabled regiodivergent C-H bond functionalization of naphthols with α-aryl-α-diazoesters.
    Yu Z; Li Y; Zhang P; Liu L; Zhang J
    Chem Sci; 2019 Jul; 10(26):6553-6559. PubMed ID: 31367307
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of besipirdine at the voltage-dependent sodium channel.
    Tang L; Smith CP; Huger FP; Kongsamut S
    Br J Pharmacol; 1995 Nov; 116(5):2468-72. PubMed ID: 8581286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes.
    Ratnakumari L; Hemmings HC
    Anesthesiology; 1997 Feb; 86(2):428-39. PubMed ID: 9054261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protection against veratridine toxicity in rat cortical cultures: relationship to sodium channel blockade.
    Lakics V; Molnár P; Erdö SL
    Neuroreport; 1995 Dec; 7(1):89-92. PubMed ID: 8742424
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.
    Roufos I; Hays SJ; Dooley DJ; Schwarz RD; Campbell GW; Probert AW
    J Med Chem; 1994 Jan; 37(2):268-74. PubMed ID: 8295214
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A structure-activity relationship study of novel phenylacetamides which are sodium channel blockers.
    Roufos I; Hays S; Schwarz RD
    J Med Chem; 1996 Mar; 39(7):1514-20. PubMed ID: 8691482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.
    Thomsen W; Hays SJ; Hicks JL; Schwarz RD; Catterall WA
    Mol Pharmacol; 1993 Jun; 43(6):955-64. PubMed ID: 8391120
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.